SOPHiA GENETICS (SOPH) Capital Expenditures (2020 - 2025)

SOPHiA GENETICS has disclosed Capital Expenditures across 6 years of filings, most recently posting -$338000.0 for Q4 2025.

• Capital Expenditures for Q4 2025 came in at -$338000.0, down 492.98% year-over-year; the trailing twelve-month figure through Dec 2025 was -$574000.0 (down 135.25% YoY), and the FY2025 annual result was -$574000.0, down 135.25% from the prior year.
• Capital Expenditures came in at -$338000.0 for Q4 2025 at SOPHiA GENETICS, down from -$106000.0 in the prior quarter.
• In the past five years, Capital Expenditures ranged from a high of $1.3 million in Q2 2025 to a low of -$1.9 million in Q4 2022.
• The 5-year median for Capital Expenditures is -$244500.0 (2021), against an average of -$454600.0.
• Across the five-year window, Capital Expenditures slumped 1396.51% in 2021 and jumped 11058.33% in 2025, its largest moves.
• SOPHiA GENETICS's Capital Expenditures stood at -$151000.0 in 2021, then plunged by 1172.19% to -$1.9 million in 2022, then surged by 93.49% to -$125000.0 in 2023, then surged by 54.4% to -$57000.0 in 2024, then tumbled by 492.98% to -$338000.0 in 2025.
• The last three Capital Expenditures figures came in at -$338000.0 (Q4 2025), -$106000.0 (Q3 2025), and $1.3 million (Q2 2025), per Business Quant data.